HCMT
ACIU icon

Highland Capital Management (Texas)’s AC Immune ACIU Stock Holding History

Highland Capital Management (Texas)’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-87,900
Closed -$1.45M – 286
2016
Q3 		$1.45M Buy
+87,900
New +$1.52M 0.04% 179

Other funds holding ACIU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Highland Capital Management (Texas)'s ACIU Position: Q4 2016 in Review

Highland Capital Management (Texas) sold out of AC Immune (ACIU) in Q4 2016, closing a stake of 87,900 shares — an estimated $1.45M sold.

Highland Capital Management (Texas) first reported a position in ACIU in Q3 2016 and held it in 1 quarter. The position peaked at $1.45M in Q3 2016. 19 funds tracked by Wall St. Rank hold ACIU as of Q4 2016.

  • Highland Capital Management (Texas) reported no remaining AC Immune position as of Q4 2016 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 87,900 AC Immune shares in Q4 2016, an estimated $1.45M.
  • Highland Capital Management (Texas) first reported a position in AC Immune in Q3 2016 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s AC Immune position peaked at $1.45M in Q3 2016.
  • 19 funds tracked by Wall St. Rank held AC Immune as of Q4 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2016, filed 13 Feb 2017.